Drug-resistant bacteria use several families of membrane-embedded transporters to remove antibiotics from the cell. One such family is the small multidrug resistance proteins (SMRs) that, because of their relatively small size (ca. 110 residues with four transmembrane [TM] helices), must form (at least) dimers to efflux drugs. Here, we use a Lys-tagged synthetic peptide with exactly the same sequence as TM4 of the full-length SMR Hsmr from Halobacterium salinarum [TM4 sequence: AcA(Sar) 3 -VAGVVGLALIVAGVVVLNVAS-KKK (Sar ؍ N-methylglycine)] to compete with and disrupt the native TM4-TM4 interactions believed to constitute the locus of Hsmr dimerization. Using a cellular efflux assay of the fluorescent SMR substrate ethidium bromide, we determined that bacterial cells containing Hsmr are able to remove cellular ethidium via first-order exponential decay with a rate constant (k) of 10.1 ؋ 10 ؊3 ؎ 0.7 ؋ 10 ؊3 s ؊1 . Upon treatment of the cells with the TM4 peptide, we observed a saturable ϳ60% decrease in the efflux rate constant to 3.7 ؋ 10 ؊3 ؎ 0.2 ؋ 10 ؊3 s ؊1 . In corresponding experiments with control peptides, including scrambled sequences and a sequence with D-chirality, a decrease in ethidium efflux either was not observed or was marginal, likely from nonspecific effects. The designed peptides did not evoke bacterial lysis, indicating that they act via the ␣-helicity and membrane insertion propensities of the native TM4 helix. Our overall results suggest that this approach could conceivably be used to design hydrophobic peptides for disruption of key TM-TM interactions of membrane proteins and represent a valuable route to the discovery of new therapeutics.
Bacteria effectively use membrane-bound efflux transporters to remove cytotoxic compounds as a mechanism of multidrug resistance (25). Among the five families of bacterial multidrug transporters, at least two have been shown to require oligomerization for function: the resistance nodulation division (RND) and the small multidrug resistance (SMR) proteins (6,22,25). These families are both found in pathogenic Gram-negative bacteria, such as Escherichia coli, Pseudomonas aeruginosa, and Mycobacterium tuberculosis, while SMRs are also found in Gram-positive bacteria and archaebacteria, such as Staphylococcus aureus and Halobacterium salinarum, respectively (1, 25). Like many effluxers, SMRs use the proton motive force (PMF) to facilitate the removal of various cationic sanitizing agents, dyes, and antibiotics from the bacterial cell (1,12,15,18,19,23,27,29,36).SMR proteins are relatively small compared to the other multidrug efflux families (which often efflux the same molecules, such as ethidium bromide) and are comprised of ϳ110 residues that consist of four membrane-spanning (transmembrane [TM]) ␣-helices with short connecting loops (6). The minimal functional unit of SMRs has been characterized as a dimer, although higherorder oligomerization has also been proposed (4,9,33,36,37,39,40,42). EmrE from E. coli is the most extensively studied SMR family me...